Endocrinology, Vol 130, 1707-1715, Copyright © 1992 by Endocrine Society

ARTICLES

Presence of transforming growth factor-beta and their selective cellular localization in human ovarian tissue of various reproductive stages

N Chegini and KC Flanders
Department of Obstetric and Gynecology, University of Florida, Gainesville 32610.

Immunohistochemical studies were performed using specific polyclonal antibodies to transforming growth factor (TGF)-beta 1 and TGF-beta 2 to determine their presence and cellular localization in human ovarian tissues of various reproductive states. In the small ovarian follicles, the immunostaining for TGF-beta 1 was present in oocytes, follicle cells, and granulosa and theca cell layers. The level of immunostaining associated with granulosa and theca cell layers intensified as the size of the follicles increased. In the luteal tissue, both the small and large luteal cells immunostained for TGF-beta 1 and their intensities were similar to theca and granulosa cell layers, respectively. The patterns of immunostaining were similar in early (days 14-19), mid (days 22-25), and late (days 26-29) luteal phases; however, the intensity was highest at mid and decreased at late luteal phase. Corpus albicans showed a very weak immunostaining for TGF-beta 1, whereas ectopic pregnancy small luteal cells immunostained relatively intensely. The ovarian stromal, luteal tissue fibroblasts, and arterioles endothelial and smooth muscle cells were also immunostained for TGF-beta 1. The immunostaining of the ovarian tissues for TGF-beta 2 indicated that the theca cell layers were the exclusive cells in the follicles with intense immunostaining, which increased in the larger follicles. A low immunostaining was also observed in granulosa cell of the large follicles. In the luteal tissues, only small luteal cells showed intense immunostaining for TGF-beta 2, which was similar in intensity to that in the theca cells; however, the large luteal cells showed a low level of immunostaining at midluteal phase. The small luteal cells in corpus albicans and ectopic pregnancy luteal tissues retained their immunostaining for TGF-beta 2, but with lower intensity. Endothelial and smooth muscle cells of arterioles also immunostained for TGF-beta 2, but not ovarian stromal cells. Atretic follicles showed very low or no detectable immunostaining for TGF-beta 1 or TGF-beta 2. The results of present studies show that human ovarian tissue at all the reproductive states locally produces TGF-beta 1 and TGF-beta 2, and although TGF-beta 1 is present in most major ovarian cell types, TGF- beta 2 is only produced by theca cells in the follicles and small luteal cells in luteal tissues.

This article has been cited by other articles:

				W. V. Ingman, R. L. Robker, K. Woittiez, and S. A. Robertson Null Mutation in Transforming Growth Factor {beta}1 Disrupts Ovarian Function and Causes Oocyte Incompetence and Early Embryo Arrest Endocrinology, February 1, 2006; 147(2): 835 - 845. [Abstract] [Full Text] [PDF]

				J.L. Juengel and K.P. McNatty The role of proteins of the transforming growth factor-{beta} superfamily in the intraovarian regulation of follicular development Hum. Reprod. Update, March 1, 2005; 11(2): 144 - 161. [Abstract] [Full Text] [PDF]

				G. C. Rodriguez, N. P. Nagarsheth, K. L. Lee, R. C. Bentley, D. K. Walmer, M. Cline, R. S. Whitaker, P. Isner, A. Berchuck, R. K. Dodge, et al. Progestin-Induced Apoptosis in the Macaque Ovarian Epithelium: Differential Regulation of Transforming Growth Factor-{beta} J Natl Cancer Inst, January 2, 2002; 94(1): 50 - 60. [Abstract] [Full Text] [PDF]

				C. A. Dooley, G. R. Attia, W. E. Rainey, D. R. Moore, and B. R. Carr Bone Morphogenetic Protein Inhibits Ovarian Androgen Production J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3331 - 3337. [Abstract] [Full Text]

				C. Osterlund and G. Fried TGF{beta} receptor types I and II and the substrate proteins Smad 2 and 3 are present in human oocytes Mol. Hum. Reprod., June 1, 2000; 6(6): 498 - 503. [Abstract] [Full Text] [PDF]

				J. Qu, P. A. Godin, M. Nisolle, and J. Donnez Expression of receptors for insulin-like growth factor-I and transforming growth factor-{beta} in human follicles Mol. Hum. Reprod., February 1, 2000; 6(2): 137 - 145. [Abstract] [Full Text] [PDF]

				R. J. Zachow, S. R. Weitsman, and D. A. Magoffin Leptin Impairs the Synergistic Stimulation by Transforming Growth Factor-{beta} of Follicle-Stimulating Hormone-Dependent Aromatase Activity and Messenger Ribonucleic Acid Expression in Rat Ovarian Granulosa Cells Biol Reprod, October 1, 1999; 61(4): 1104 - 1109. [Abstract] [Full Text]

				M. E. Gordinier, H.-Z. Zhang, R. Patenia, L. B. Levy, E. N. Atkinson, M. A. Nash, R. L. Katz, C. D. Platsoucas, and R. S. Freedman Quantitative Analysis of Transforming Growth Factor {beta}1 and 2 in Ovarian Carcinoma Clin. Cancer Res., September 1, 1999; 5(9): 2498 - 2505. [Abstract] [Full Text] [PDF]

				S. K. Roy and D. M. Terada Activities of Glucose Metabolic Enzymes in Human Preantral Follicles: In Vitro Modulation by Follicle-Stimulating Hormone, Luteinizing Hormone, Epidermal Growth Factor, Insulin-Like Growth Factor I, and Transforming Growth Factor ß1 Biol Reprod, March 1, 1999; 60(3): 763 - 768. [Abstract] [Full Text]

				L. Song, D. G. Porter, and B. L. Coomber Production of Gelatinases and Tissue Inhibitors of Matrix Metalloproteinases by Equine Ovarian Stromal Cells In Vitro Biol Reprod, January 1, 1999; 60(1): 1 - 7. [Abstract] [Full Text]